- Protocol Short Name and Number: CureAA, 2207
- Protocol Long Name: A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients with Severe Aplastic Anemia
- Protocol (PDF)
- ICFs (PDF)
- FAQs (TBD)
- Key Personnel
- BMT CTN # 2207 Co-Chair: Amy DeZern, MD
- BMT CTN # 2207 Co-Chair: Sally Arai, MD
- BMT CTN # 2207 Protocol Officer: Larisa Broglie, MD
- BMT CTN # 2207 Protocol Coordinator: bmtctn2207@emmes.com
- Keywords: Aplastic Anemia, AA, Severe Aplastic Anemia, SAA, Haplo, Haploidentical Transplant, Allo Transplant, Allogeneic Transplant, Matched Unrelated Transplant, MUD, Thymoglobulin®, anti-thymocyte globulin (rabbit), ATG, Sanofi